{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/uveitis/background-information/complications/","result":{"pageContext":{"chapter":{"id":"c59a26aa-291d-58eb-ad48-cb4dded2b859","slug":"complications","fullItemName":"Complications","depth":2,"htmlHeader":"<!-- begin field 02dd15b3-919b-4094-84b9-efb406fb1199 --><h2>What are the complications?</h2><!-- end field 02dd15b3-919b-4094-84b9-efb406fb1199 -->","summary":"","htmlStringContent":"<!-- begin item 236cddb3-8f33-44a6-9c18-88722c71b3ec --><!-- begin field 858750c4-39a5-47b3-9a70-690b9341e665 --><ul><li><strong>Vision loss </strong>— uveitis is implicated in up to 25% of cases of legal blindness in the developing world.<ul><li>The major causes of vision loss in people with uveitis are cystoid macular oedema, secondary cataract, and secondary glaucoma.</li></ul></li><li><strong>Visual impairment </strong>— uveitis accounts for approximately 5–10% of visual impairment worldwide and up to 35% of all people with uveitis suffer from significant visual loss to legal blindness. </li><li><strong>Paediatric uveitis </strong>is associated with a tendency for chronicity, high complication rates, and severe visual impairment. <ul><li>About one-third of children with uveitis suffer severe visual loss.</li></ul></li><li><strong>Other complications caused by uveitis include: </strong><ul><li>Band keratopathy (calcium deposits in the cornea). </li><li>Cataract (secondary to the disease process or corticosteroid treatment). </li><li>Glaucoma (secondary to the disease process or corticosteroid treatment). </li><li>Cystoid macular oedema (the most common cause of visual impairment in people with uveitis). </li><li>Posterior synechiae (adhesions between the posterior iris and the anterior lens surface). </li><li>Hypotony (low intraocular pressure). </li><li>Macular cyst/hole, macular puckering or macular ischaemia. </li><li>Retinal detachment (exudative and tractional) or retinal scars.</li><li>Choroidal and retinal neovascularization. </li><li>Optic neuropathy or optic atrophy. </li><li>Vitreous opacities and vitreous haemorrhage.</li><li>Phthisis (shrinkage of the globe). </li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">Guly, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">Tomkins-Netzer, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">Dick, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">BMJ, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">Constantin, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">Tsirouki, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/uveitis/references/\">MSD, 2019</a>]</p><!-- end field 858750c4-39a5-47b3-9a70-690b9341e665 --><!-- end item 236cddb3-8f33-44a6-9c18-88722c71b3ec -->","topic":{"id":"4e7f8958-fe40-50b7-8ec8-2b083c8f6d9f","topicId":"5ed561ca-031e-4b81-b7b9-983a4596f57d","topicName":"Uveitis","slug":"uveitis","lastRevised":"Last revised in November 2019","chapters":[{"id":"c1e5701f-4cf7-5b69-b095-728c2e750a2e","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"b652ef07-4a12-5bb0-a4b9-c1094cf2e1d2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2207db21-1f9e-5e39-93b5-7fc6a06aa966","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1a49d275-1794-5c25-90df-8f0530f899ec","slug":"changes","fullItemName":"Changes"},{"id":"da048924-1bce-5637-a71a-d7ff26956aa2","slug":"update","fullItemName":"Update"}]},{"id":"db656a2f-7785-5776-ae8b-48cdfd7756f8","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"47bb0526-e4db-56a3-a194-a706b3b3140c","slug":"goals","fullItemName":"Goals"},{"id":"1f8904c0-9580-5baa-9124-abb6169557cb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e4f30ebb-13db-5f25-8c8c-2922bf0324c2","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c38307ad-dc15-5b55-9372-253747056a05","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a5a31d4b-de2a-54ff-81c0-6c61354951a9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3f8284ba-ca4f-5550-891b-a8bb66ae561a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d254b372-3c06-50bd-a365-07955b3fb044","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"40e37db0-0ff9-5e4e-a5d9-a3961f2ae4ef","slug":"definition","fullItemName":"Definition"},{"id":"a22de773-ef70-5bde-b110-c2f1262f2190","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"3315c723-dddf-57fc-84b3-dc09ea047f7b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c59a26aa-291d-58eb-ad48-cb4dded2b859","slug":"complications","fullItemName":"Complications"},{"id":"36d5a1d4-9b5d-5c62-81e5-0c43edd11e00","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"0cfa2942-a69a-5096-8ae9-f7861442f3f6","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e5becea0-9248-5f2a-83e3-24b1e3d4ce6b","slug":"assessment","fullItemName":"Assessment"},{"id":"a9640992-20d3-5ba2-bdd7-ec93af987f32","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4047e2b5-894c-544b-b383-bff07703393f","fullItemName":"Management","slug":"management","subChapters":[{"id":"4979504e-a9bf-5af0-85e3-9dc3768f890c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"df7eae5d-b45a-51a6-a36f-a765d5316352","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ce1f7b0f-39da-5d16-bebb-8843f476896e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4c41e5af-5272-5e11-9e17-c8316e740974","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"552ccc38-bb09-5038-bc2c-1c084a3b1ee9","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"06fa45da-6a9c-586f-b111-cfdb08482ec5","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5c6898e0-edbd-5964-adb0-5002730568b9","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2e9caef7-3fad-5071-a98a-9facdf639f41","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1d32651a-229f-569e-914a-25bba4c7f533","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d254b372-3c06-50bd-a365-07955b3fb044","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}